State of the Art and Perspectives in Retinal Pigment Epithelium
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Cellular Biochemistry".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 1502
Special Issue Editors
Interests: translational research in oncology, onco-hematology, cardiovascular and metabolic diseases, eye diseases physiopathology and therapies; preclinical testing of innovative molecule/drugs and delivery systems
Special Issues, Collections and Topics in MDPI journals
Interests: cell and molecular biology; anticancer and antiinflammatory effects of new compounds; flow cytometry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Retinal pigment epithelium (RPE) plays a fundamental role in retina physiopathology and in visual function maintenance. Indeed, first of all, it guarantees photoreceptor renewal, through its phagocytic activity; RPE also contributes to the establishment of the blood–retinal barrier and controls incoming and outgoing molecular transports. Moreover, RPE cells can protect the neural components of the retina from light damage thanks to its melanin content and their ability to call upon several metabolic pathways that are able to enhance the scavenging of reactive oxygen species within the eye, thereby counteracting oxidative damage. Consequently, RPE integrity alterations, as well as unbalanced RPE renewal and proliferation, can lead to the development of different retinopathies, which, to date, deeply lack effective and resolutive therapies.
The focus of this Special Issue is to highlight the recent advances in RPE physiopathology and in new potential therapeutic approaches for retinopathies that have arisen from RPE dysfunctionality. Recent advances and overviews on study models, including new methodology and technologies for RPE investigation, will be considered. We also encourage the submission of reports exploring the therapeutic or ameliorative effects on retinal diseases of natural extracts, natural bioactive and synthetic molecules, or innovative delivery strategies for eye administration, including chemical hybrids and nanocarriers, or even combination treatments.
As a part of this Special Issue, we invite the submission of original manuscripts spanning basic to pre-clinical and clinical research, brief reports, meta-analysis, and narrative and systematic reviews proposing novelties or overviews in the aforementioned fields.
Prof. Dr. Paola Secchiero
Dr. Elisabetta Melloni
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinal pigment epithelium
- innovative treatments/therapeutic approaches
- retinal diseases
- bioactive molecules
- eye delivery strategy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
